The Department of Health and Social Care (DH) has issued a serious shortage protocol (SSP) for Levothyroxine 12.5mcg tablets following severe supply disruption.
Effective from Wednesday (Feb 3), SSP10 has provided pharmacists a suitable alternative product- one Levothyroxine 25mcg tablet in response to the serious shortage affecting the supply of 12.5mcg tablets.
| For prescriptions (NHS or private) requesting: | Supply permitted under SSP10: |
| Levothyroxine 12.5mcg tablets (56 tablets) | Levothyroxine25mcg tablets (28 tablets) |
The SSP is currently scheduled to expire on March 5.
The reimbursement price will account for VAT payment. Supply in accordance with the SSP will result in the following fees being paid to the contractor…
- One Single Activity fee (currently £1.27)
- One SSP fee (£5.35)
